Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal

被引：0
|
作者：
Wesley Zemrak
Francis Manuel
Kathryn E. Smith
Stephen Rolfe
Timothy Hayes
Robert L. Trowbridge
Brian Carlone
David Seder
机构：
[1] Maine Medical Center,Department of Pharmacy
[2] Mayo Clinic,Department of Pharmacy
[3] Maine Medical Center,Department of Pathology
[4] Maine Medical Center,Department of Medicine
[5] Maine Medical Center,Department of Critical Care Services
来源：
Journal of Thrombosis and Thrombolysis | 2019年 / 47卷
关键词：
Warfarin; Reversal; Prothrombin complex concentrate; Hemorrhage; PCC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 271
页数：8
相关论文
共 50 条
  • [21] Multi-centered evaluation of a novel fixed-dose four-factor prothrombin complex concentrate protocol for warfarin reversal
    Dietrich, Scott K.
    Mixon, Mark
    Holowatyj, Michael
    Werth, Josh C.
    Delgado, Stephanie A.
    Mascolo, Nicole E.
    Meister, Erin R.
    Zoucha, Shane M.
    Trujillo, Toby C.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2020, 38 (10): : 2096 - 2100
  • [22] HIGH-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR WARFARIN-INDUCED INTRACEREBRAL HEMORRHAGE
    Merchan, Cristian
    Raco, Veronica
    Ahuja, Tania
    Lewis, Ariane
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [23] Optimisation of the prothrombin complex concentrate dose for warfarin reversal
    Makris, M
    THROMBOSIS RESEARCH, 2005, 115 (06) : 451 - 453
  • [24] COMPARISON OF PROTHROMBIN COMPLEX CONCENTRATE (PCC) AND LOW-DOSE RECOMBINANT FACTOR VIIA (RFVIIA) FOR WARFARIN ANTICOAGULATION REVERSAL
    Chapman, Scott
    Irwin, Eric
    Kulinski, Nichole
    Hutson, Katherine
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U16 - U16
  • [25] Case Series of Four-Factor Prothrombin Complex Concentrate for Warfarin Reversal Before Heart Transplantation
    Nuckles, K. B.
    Pratt, J. H.
    Cameron, C. M.
    Ingemi, A. I.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (03) : 841 - 843
  • [26] Initiation of a fixed-dose four-factor prothrombin complex concentrate protocol
    Fuh, L.
    Goldstein, J. N.
    Hayes, B. D.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (01) : 217 - 220
  • [27] Reduced dosing strategy of four-factor prothrombin complex concentrate for the reversal of warfarin: An evaluation of efficacy
    Allen, J.
    Boudreau, M.
    Mikesell, K.
    Kumar, V.
    Ford, R.
    ANESTHESIA AND ANALGESIA, 2017, 125 : 31 - 31
  • [28] Initiation of a fixed-dose four-factor prothrombin complex concentrate protocol
    L. Fuh
    J. N. Goldstein
    B. D. Hayes
    Journal of Thrombosis and Thrombolysis, 2020, 50 : 217 - 220
  • [29] PROTHROMBIN COMPLEX CONCENTRATE PLUS LOW-DOSE FACTOR VIIA FOR BLEEDING AND REVERSAL OF COAGULOPATHY
    Baje, Mark
    Albicker, Paul
    Gayatinea, Regina
    Minh-Ha Tran
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [30] Fixed-Dose Four-Factor Prothrombin Complex Concentrate for Vitamin K Antagonist Reversal: Does One Dose Fit All?
    Schwebach, Alyson A.
    Waybright, Ryan A.
    Johnson, Thomas J.
    PHARMACOTHERAPY, 2019, 39 (05): : 599 - 608
12345